Ruling Could Inhibit Peer Review Candor

Reviewers will have to think twice, now that tenure evaluation letters can be used as evidence in bias cases Academic scientists who are denied tenure and then sue universities on the basis of discrimination will find little, if any, information to support their case in written evaluations submitted by their peers. In fact, tenure candidates and the universities considering them will now have difficulty even recruiting researchers to honestly evaluate colleagues' work. These, scientists and s

Written byJulia King
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share


Reviewers will have to think twice, now that tenure evaluation letters can be used as evidence in bias cases
Academic scientists who are denied tenure and then sue universities on the basis of discrimination will find little, if any, information to support their case in written evaluations submitted by their peers. In fact, tenure candidates and the universities considering them will now have difficulty even recruiting researchers to honestly evaluate colleagues' work.

These, scientists and school administrators say, are the two most likely effects of a controversial Supreme Court decision early this year that stripped universities of their privilege to hold confidential outside letters of recommendation - the backbone of all tenure review files. Now that such letters can be used as evidence by tribunals deciding discrimination cases, researchers will think twice about writing candidly, or even about writing at all, they say.

"People are going to be less likely ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies